{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:35:07Z","timestamp":1793158507993,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13760-026-03106-9","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T02:20:38Z","timestamp":1781749238000},"page":"1623-1629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlation of serum glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells-2 (sTREM-2) levels with disability and clinical characteristics in multiple sclerosis"],"prefix":"10.1007","volume":"126","author":[{"given":"Sanaz","family":"Khodadadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Rezaeimanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarlan","family":"Varzandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Montazeri-Shatouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Mohammadi Lapevandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdorreza","family":"Naser Moghadasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"1","key":"3106_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-immunol-093019-124155","volume":"39","author":"V Ramaglia","year":"2021","unstructured":"Ramaglia V, Rojas O, Naouar I, Gommerman JL (2021) The ins and outs of central nervous system inflammation\u2014lessons learned from multiple sclerosis. Annu Rev Immunol 39(1):199\u2013226","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"3106_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.msard.2013.09.004","volume":"3","author":"JD Campbell","year":"2014","unstructured":"Campbell JD, Ghushchyan V, Brett McQueen R, Cahoon-Metzger S, Livingston T, Vollmer T et al (2014) Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates. Mult Scler Relat Disord 3(2):227\u2013236","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"3106_CR3","doi-asserted-by":"publisher","first-page":"10923","DOI":"10.1038\/s41598-020-67934-2","volume":"10","author":"X Ayrignac","year":"2020","unstructured":"Ayrignac X, Le Bars E, Duflos C, Hirtz C, Maleska Maceski A, Carra-Dalli\u00e8re C et al (2020) Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity. Sci Rep 10(1):10923","journal-title":"Sci Rep"},{"key":"3106_CR4","doi-asserted-by":"publisher","first-page":"1135540","DOI":"10.3389\/fimmu.2023.1135540","volume":"14","author":"VG Coutinho Costa","year":"2023","unstructured":"Coutinho Costa VG, Ara\u00fajo SE, Alves-Leon SV, Gomes FCA (2023) Central nervous system demyelinating diseases: glial cells at the hub of pathology. Front Immunol 14:1135540","journal-title":"Front Immunol"},{"issue":"6","key":"3106_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neurol.2018.12.006","volume":"175","author":"X-B Yan","year":"2019","unstructured":"Yan X-B, Zhao Y-F, Yang Y-M, Wang N, He B-Z, Qiu X-T (2019) Impact of astrocyte and lymphocyte interactions on the blood-brain barrier in multiple sclerosis. Rev Neurol 175(6):396\u2013402","journal-title":"Rev Neurol"},{"issue":"1","key":"3106_CR6","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1038\/s41467-019-11638-3","volume":"10","author":"L Kirby","year":"2019","unstructured":"Kirby L, Jin J, Cardona JG, Smith MD, Martin KA, Wang J et al (2019) Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nat Commun 10(1):3887","journal-title":"Nat Commun"},{"issue":"1","key":"3106_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.25927","volume":"89","author":"G Comi","year":"2021","unstructured":"Comi G, Bar-Or A, Lassmann H, Uccelli A, Hartung HP, Montalban X et al (2021) Role of B cells in multiple sclerosis and related disorders. Ann Neurol 89(1):13\u201323","journal-title":"Ann Neurol"},{"issue":"8","key":"3106_CR8","doi-asserted-by":"publisher","first-page":"e37297","DOI":"10.1097\/MD.0000000000037297","volume":"103","author":"M Haki","year":"2024","unstructured":"Haki M, Al-Biati HA, Al-Tameemi ZS, Ali IS, Al-Hussaniy HA (2024) Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment. Medicine 103(8):e37297","journal-title":"Medicine"},{"issue":"12","key":"3106_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.tips.2020.09.011","volume":"41","author":"L Gaetani","year":"2020","unstructured":"Gaetani L, Paoletti FP, Bellomo G, Mancini A, Simoni S, Di Filippo M et al (2020) CSF and blood biomarkers in neuroinflammatory and neurodegenerative diseases: implications for treatment. Trends Pharmacol Sci 41(12):1023\u20131037","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"3106_CR10","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/biomedicines10071760","volume":"10","author":"D Kon\u00ed\u010dkov\u00e1","year":"2022","unstructured":"Kon\u00ed\u010dkov\u00e1 D, Men\u0161\u00edkov\u00e1 K, Tu\u010dkov\u00e1 L, H\u00e9nykov\u00e1 E, Strnad M, Friedeck\u00fd D et al (2022) Biomarkers of neurodegenerative diseases: biology, taxonomy, clinical relevance, and current research status. Biomedicines 10(7):1760","journal-title":"Biomedicines"},{"issue":"2","key":"3106_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/jnnp-2020-323520","volume":"92","author":"IJ Swift","year":"2021","unstructured":"Swift IJ, Sogorb-Esteve A, Heller C, Synofzik M, Otto M, Graff C et al (2021) Fluid biomarkers in frontotemporal dementia: past, present and future. J Neurol Neurosurg Psychiatry 92(2):204\u2013215","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3106_CR12","doi-asserted-by":"publisher","first-page":"805953","DOI":"10.3389\/fnins.2022.805953","volume":"16","author":"Q Li","year":"2022","unstructured":"Li Q, Li Z, Han X, Shen X, Wang F, Bai L et al (2022) A panel of plasma biomarkers for differential diagnosis of parkinsonian syndromes. Front NeuroSci 16:805953","journal-title":"Front NeuroSci"},{"issue":"1","key":"3106_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh S-H (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Translational neurodegeneration 9(1):42","journal-title":"Translational neurodegeneration"},{"issue":"4","key":"3106_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.14283\/jpad.2023.109","volume":"10","author":"M Kiraly","year":"2023","unstructured":"Kiraly M, Foss J, Giordano T (2023) Neuroinflammation, its role in Alzheimer\u2019s disease and therapeutic strategies. J Prev Alzheimer\u2019s Disease 10(4):686\u2013698","journal-title":"J Prev Alzheimer\u2019s Disease"},{"issue":"2","key":"3106_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/biom12020222","volume":"12","author":"F Azzolini","year":"2022","unstructured":"Azzolini F, Gilio L, Pavone L, Iezzi E, Dolcetti E, Bruno A et al (2022) Neuroinflammation is associated with GFAP and sTREM2 levels in multiple sclerosis. Biomolecules 12(2):222","journal-title":"Biomolecules"},{"issue":"3","key":"3106_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamaneurol.2022.5250","volume":"80","author":"S Meier","year":"2023","unstructured":"Meier S, Willemse EA, Schaedelin S, Oechtering J, Lorscheider J, Melie-Garcia L et al (2023) Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis. JAMA Neurol 80(3):287\u2013297","journal-title":"JAMA Neurol"},{"issue":"2","key":"3106_CR17","doi-asserted-by":"publisher","first-page":"205521732110197","DOI":"10.1177\/20552173211019772","volume":"7","author":"ZA Ioannides","year":"2021","unstructured":"Ioannides ZA, Csurhes PA, Swayne A, Foubert P, Aftab BT, Pender MP (2021) Correlations between macrophage\/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis. Multiple Scler Journal\u2013Experimental Translational Clin 7(2):20552173211019772","journal-title":"Multiple Scler Journal\u2013Experimental Translational Clin"},{"key":"3106_CR18","doi-asserted-by":"publisher","first-page":"103280","DOI":"10.1016\/j.msard.2021.103280","volume":"56","author":"M Niiranen","year":"2021","unstructured":"Niiranen M, Kontkanen A, J\u00e4\u00e4skel\u00e4inen O, Tertsunen H-M, Selander T, Hartikainen P et al (2021) Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis. Multiple Scler Relat Disorders 56:103280","journal-title":"Multiple Scler Relat Disorders"},{"issue":"9","key":"3106_CR19","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1177\/13524585231176732","volume":"29","author":"X Jiang","year":"2023","unstructured":"Jiang X, Shen C, Teunissen CE, Wessels M, Zetterberg H, Giovannoni G et al (2023) Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation. Multiple Scler J 29(9):1070\u20131079","journal-title":"Multiple Scler J"},{"issue":"2","key":"3106_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10072-012-0974-4","volume":"34","author":"R Madeddu","year":"2013","unstructured":"Madeddu R, Farace C, Tolu P, Solinas G, Asara Y, Sotgiu MA et al (2013) Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis. Neurol Sci 34(2):181\u2013186","journal-title":"Neurol Sci"},{"key":"3106_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.brainres.2014.12.027","volume":"1600","author":"A Petzold","year":"2015","unstructured":"Petzold A (2015) Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease. Brain Res 1600:17\u201331","journal-title":"Brain Res"},{"issue":"19","key":"3106_CR22","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1093\/hmg\/ddaa209","volume":"29","author":"W Liu","year":"2020","unstructured":"Liu W, Taso O, Wang R, Bayram S, Graham AC, Garcia-Reitboeck P et al (2020) Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions. Hum Mol Genet 29(19):3224\u20133248","journal-title":"Hum Mol Genet"},{"issue":"2","key":"3106_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/1352458518819380","volume":"26","author":"H H\u00f6gel","year":"2020","unstructured":"H\u00f6gel H, Rissanen E, Barro C, Matilainen M, Nylund M, Kuhle J et al (2020) Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity. Multiple Scler J 26(2):210\u2013219","journal-title":"Multiple Scler J"},{"issue":"1","key":"3106_CR24","doi-asserted-by":"publisher","first-page":"14798","DOI":"10.1038\/s41598-018-33158-8","volume":"8","author":"A Abdelhak","year":"2018","unstructured":"Abdelhak A, Huss A, Kassubek J, Tumani H, Otto M (2018) Serum GFAP as a biomarker for disease severity in multiple sclerosis. Sci Rep 8(1):14798","journal-title":"Sci Rep"},{"key":"3106_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fnagi.2018.00238","volume":"10","author":"A Musella","year":"2018","unstructured":"Musella A, Gentile A, Rizzo FR, De Vito F, Fresegna D, Bullitta S et al (2018) Interplay between age and neuroinflammation in multiple sclerosis: effects on motor and cognitive functions. Front Aging Neurosci 10:238","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"3106_CR26","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.bbi.2011.12.008","volume":"26","author":"I Kremsky","year":"2012","unstructured":"Kremsky I, Morgan TE, Hou X, Li L, Finch CE (2012) Age-changes in gene expression in primary mixed glia cultures from young vs. old rat cerebral cortex are modified by interactions with neurons. Brain Behav Immun 26(5):797\u2013802","journal-title":"Brain Behav Immun"},{"issue":"1\u20132","key":"3106_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0022-510X(95)00152-R","volume":"133","author":"L Rosengren","year":"1995","unstructured":"Rosengren L, Lycke J, Andersen O (1995) Glial fibrillary acidic protein in CSF of multiple sclerosis patients: relation to neurological deficit. J Neurol Sci 133(1\u20132):61\u201365","journal-title":"J Neurol Sci"},{"key":"3106_CR28","doi-asserted-by":"publisher","first-page":"106268","DOI":"10.1016\/j.msard.2025.106268","volume":"94","author":"M Tolentino","year":"2025","unstructured":"Tolentino M, Pace F, Perantie DC, Mikesell R, Huecker J, Chahin S et al (2025) Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severity. Multiple Scler Relat Disorders 94:106268","journal-title":"Multiple Scler Relat Disorders"},{"issue":"12","key":"3106_CR29","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1212\/01.WNL.0000098880.19793.B6","volume":"61","author":"C Malmestrom","year":"2003","unstructured":"Malmestrom C, Haghighi S, Rosengren L, Andersen O, Lycke J (2003) Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS. Neurology 61(12):1720\u20131725","journal-title":"Neurology"},{"key":"3106_CR30","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3389\/fimmu.2020.01416","volume":"11","author":"A Matejuk","year":"2020","unstructured":"Matejuk A, Ransohoff RM (2020) Crosstalk Between Astrocytes and Microglia: An Overview. Front Immunol 11:1416","journal-title":"Front Immunol"},{"issue":"7638","key":"3106_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481\u2013487","journal-title":"Nature"},{"issue":"4","key":"3106_CR32","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","volume":"108","author":"M Linnerbauer","year":"2020","unstructured":"Linnerbauer M, Wheeler MA, Quintana FJ (2020) Astrocyte Crosstalk in CNS Inflammation. Neuron 108(4):608\u2013622","journal-title":"Neuron"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03106-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03106-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03106-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:59:36Z","timestamp":1793156376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03106-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3106"],"URL":"https:\/\/doi.org\/10.1007\/s13760-026-03106-9","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sanaz Khodadadi, Nasim Rezaeimanesh, Ali Rezaei, Majid Hamidi, Tarlan Varzandi, Reyhaneh Montazeri-Shatouri, Mahsa Mohammadi Lapevandani: The authors declare no conflict of interest. Abdorreza Naser Moghadasi and Mohammad Ali Sahraian has received educational, research grants, lecture honorarium, travel supports to attend scientific meetings from Biogen-Idec, Merck-Serono, Cinnagen, Zistdaru, Zahravi and Genzyme.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}